Condition
Effects of Immunosuppressant Therapy
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02062944Not ApplicableCompleted
SRL (Sirolimus) Withdrawal
NCT02540395Not ApplicableCompleted
Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation
NCT02608606Not ApplicableCompleted
Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors
NCT01777204Unknown
Gastrointestinal Transit and Motility in Renal Transplant Recipients
Showing all 4 trials